- Revenue 2025
- $7,257,825
- Expenses 2025
- $8,582,631
Program services were 71.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- E80
- Classification
- 2000
- Street
- 5911 KINGSTOWNE VILLAGE PKWY 130
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2025
Mission
Optimizing health by advancing the quality of medication use.
-
Quality Measurement - PQA is a developer and steward of medication-use quality measures focused on medication safety, adherence, and appropriate use. Through a transparent, consensus-based process, PQA develops, tests, refines, and maintains measures that address gaps in priority areas and support national quality goals. PQA quality measures are used in CMS quality programs, including Medicare Part D, the Health Insurance Marketplace, and Medicaid. More than 150 million people are enrolled in health plans that report PQA measure results, making them among the most impactful tools for optimizing medication therapy, driving positive impacts for patients, and substantial costs avoided for the health care system as a whole.
Expenses $2,470,109 · Revenue $2,381,208
-
Research - The PQA Quality Innovation and Research Center (QuIRC) advances the science of medication-use quality through research, innovation, and collaboration. QuIRC develops next-generation quality measures and tools, identifies opportunities to improve medication use and management, and supports effective measure implementation through pilot projects, demonstration programs, research initiatives, and consensus-building activities. By bringing together key stakeholders, QuIRC helps address complex challenges and improve patient outcomes. In 2025, PQA's research initiatives advanced efforts to identify methodologies for evaluating adherence and persistence to oral anticancer medications; identified strategies to improve the quality of medication therapy management (MTM); and piloted pharmacy-based immunization measure concepts in value-based arrangements.
Expenses $1,203,861
-
Education and Convening - PQA advances healthcare quality through education and convening programs that promote the use and impact of quality measures and improve medication use. PQA provides continuing education, conferences, leadership forums, and other learning opportunities for healthcare professionals and quality leaders focused on medication use quality, measure implementation, and health care innovation. More than 680 people participated in PQA meetings and events in 2025.
Expenses $2,425,931 · Revenue $986,585
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2025
As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Micah Cost
Chief Executive Officer
- Total calculated
- $496,641
- From this org
- $434,436
- From related orgs
- $0
- Other
- $62,205
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $361,530
- Bonus
- $72,306
- Other
- $600
- Deferred
- $41,132
- Nontaxable benefits
- $21,073
- Filer's total
- $496,641
-
Jim Kirby
Chair
- Total calculated
- $0
- Hours/week
- 1
-
Jeff Rochon
Vice Chair
- Total calculated
- $0
- Hours/week
- 1
-
JW Hill
Secretary
- Total calculated
- $0
- Hours/week
- 1
-
Christopher Powers
Treasurer
- Total calculated
- $0
- Hours/week
- 1
-
Susan Cantrell
Immediate Past Chair
- Total calculated
- $0
- Hours/week
- 1
-
Amina Abubakar
Director
- Total calculated
- $0
- Hours/week
- 1
-
Anita Patel
Director
- Total calculated
- $0
- Hours/week
- 1
-
Brian Nightengale
Director
- Total calculated
- $0
- Hours/week
- 1
-
Ceci Connolly
Director
- Total calculated
- $0
- Hours/week
- 1
-
Crystal Lennartz
Director
- Total calculated
- $0
- Hours/week
- 1
-
Deanna Horner
Director
- Total calculated
- $0
- Hours/week
- 1
-
James Gartner
Director
- Total calculated
- $0
- Hours/week
- 1
-
Justin Bioc
Director
- Total calculated
- $0
- Hours/week
- 1
-
Lauren Esterly
Director
- Total calculated
- $0
- Hours/week
- 1
-
Lauren Lyles-Stolz
Director
- Total calculated
- $0
- Hours/week
- 1
-
Laurin Dixon
Director
- Total calculated
- $0
- Hours/week
- 1
-
Michael Johnsrud
Director
- Total calculated
- $0
- Hours/week
- 1
-
Michelle Ketcham
Director
- Total calculated
- $0
- Hours/week
- 1
-
Parmjit Agarwal
Director
- Total calculated
- $0
- Hours/week
- 1
-
Scott Dell
Director
- Total calculated
- $0
- Hours/week
- 1
-
Shantanu Agrawal
Director
- Total calculated
- $0
- Hours/week
- 1
-
Sheila Arquette
Director
- Total calculated
- $0
- Hours/week
- 1
-
Theresa Tolle
Director
- Total calculated
- $0
- Hours/week
- 1
-
Tricia Lee Rolle
Director
- Total calculated
- $0
- Hours/week
- 1
The first 25 listed. Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2025
- Revenue
- $7,257,825
- Expenses
- $8,582,631
- Contributions
- $3,035,938
- Grants paid
- $0
-
2023
- Revenue
- $6,566,364
- Expenses
- $6,711,529
- Contributions
- $3,808,554
- Grants paid
- $0
-
2022
- Revenue
- $6,645,194
- Expenses
- $5,987,450
- Contributions
- $4,283,430
- Grants paid
- $0
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $6,455,435
- Expenses
- $5,345,043
- Assets (EOY)
- $9,185,809
-
2020 · 990
- Revenue
- $6,274,540
- Expenses
- $5,380,343
- Assets (EOY)
- $7,664,287
-
2019 · 990
- Revenue
- $5,630,783
- Expenses
- $5,213,178
- Assets (EOY)
- $6,841,804
-
2018 · 990
- Revenue
- $5,038,975
- Expenses
- $4,748,761
- Assets (EOY)
- $5,602,361
-
2017 · 990
- Revenue
- $4,874,909
- Expenses
- $3,896,830
- Assets (EOY)
- $5,181,725
-
2016 · 990
- Revenue
- $4,382,741
- Expenses
- $3,583,794
- Assets (EOY)
- $4,324,562
-
2015 · 990
- Revenue
- $4,251,772
- Expenses
- $2,934,167
- Assets (EOY)
- $3,591,435
-
2014 · 990
- Revenue
- $3,141,223
- Expenses
- $2,430,132
- Assets (EOY)
- $2,225,286
-
2013 · 990
- Revenue
- $2,584,249
- Expenses
- $2,237,299
- Assets (EOY)
- $1,612,787
-
2011 · 990
- Revenue
- not reported
- Expenses
- $1,766,647
- Assets (EOY)
- $1,415,183
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.
Grants received
-
AMERICAN PHARMACISTS ASSOCIATION
$17,500
2023 MEMBERSHIP DUES
-
AMERICAN PHARMACISTS ASSOCIATION
$16,995
2022 DUES
Taxable family
From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.
Related corporations and trusts on its 2023 return
-
PHARMACY QUALITY SOLUTIONS
C · PHARMACY SOLUTIONS · DE · 51% owned · share of income $5,604,869 · share of assets $3,837,731
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 11 November 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 9 November 2026 and read 9 November 2026, for every organization at once. Returns through tax year 2025, the newest we have parsed for this organization.